Pfizer Set to Finalize $43 Billion Acquisition of Seagen
Pfizer, the renowned New York drugmaker, has successfully obtained all necessary regulatory approvals for its groundbreaking $43 billion acquisition of the biotech cancer specialist, Seagen. The company is now poised…